| Dr Edward D Reese, MD | |
|
2360 Katy Ln, Poplar Bluff, MO 63901-2300 | |
| (573) 712-2546 | |
| Not Available |
| Full Name | Dr Edward D Reese |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 2360 Katy Ln, Poplar Bluff, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013279918 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2021013100 (Missouri) | Secondary |
| 207Q00000X | Family Medicine | 6757 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ozark Home Healthcare | Poplar bluff, MO | Home health agency |
| Poplar Bluff Regional Medical Center | Poplar bluff, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Poplar Bluff Hma Physician Management, Llc | 5092769703 | 37 |
News Archive
In a new study researchers have found that Australia ranks near the top when it comes to alcohol abuse. The study was conducted by the National Drug and Alcohol Research Centre (NDARC) and it found that one in five Australians has a drinking problem and four in five go untreated for these problems. Professor Maree Teesson and her team analyzed data collected from almost 9,000 Australians aged 16 to 85 years for the National Survey of Mental Health and Wellbeing in 2007.
VNUS Medical Technologies, Inc. today announced that the U.S. Patent & Trademark Office has decided to allow a second continuation patent application related to the patents in the VNUS patent infringement lawsuit against suppliers of endovenous laser products. This comes on the heels of the Patent Office's decision last month to allow VNUS a separate patent application, also filed as a continuation of one of the patents in the lawsuit.
OncoSec Medical Inc., a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announces it has established the University of California San Francisco (UCSF) as the second enrolling site for its Phase II Merkel cell carcinoma clinical trial (OMS-I110).
RCSI University of Medicine and Health Sciences and LEO Pharma have partnered to better understand the role of a blood clotting protein in the spread of breast cancer.
Two new clinical reports shed light on why some people suffer from recurrent episodes of idiopathic anaphylaxis-a potentially life-threatening condition of unknown cause characterized by a drop in blood pressure, fainting episodes, difficulty in breathing, and wheezing.
› Verified 6 days ago
| Entity Name | Poplar Bluff Hma Physician Management, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598710147 PECOS PAC ID: 5092769703 Enrollment ID: O20050307000013 |
News Archive
In a new study researchers have found that Australia ranks near the top when it comes to alcohol abuse. The study was conducted by the National Drug and Alcohol Research Centre (NDARC) and it found that one in five Australians has a drinking problem and four in five go untreated for these problems. Professor Maree Teesson and her team analyzed data collected from almost 9,000 Australians aged 16 to 85 years for the National Survey of Mental Health and Wellbeing in 2007.
VNUS Medical Technologies, Inc. today announced that the U.S. Patent & Trademark Office has decided to allow a second continuation patent application related to the patents in the VNUS patent infringement lawsuit against suppliers of endovenous laser products. This comes on the heels of the Patent Office's decision last month to allow VNUS a separate patent application, also filed as a continuation of one of the patents in the lawsuit.
OncoSec Medical Inc., a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announces it has established the University of California San Francisco (UCSF) as the second enrolling site for its Phase II Merkel cell carcinoma clinical trial (OMS-I110).
RCSI University of Medicine and Health Sciences and LEO Pharma have partnered to better understand the role of a blood clotting protein in the spread of breast cancer.
Two new clinical reports shed light on why some people suffer from recurrent episodes of idiopathic anaphylaxis-a potentially life-threatening condition of unknown cause characterized by a drop in blood pressure, fainting episodes, difficulty in breathing, and wheezing.
› Verified 6 days ago
| Entity Name | Poplar Bluff Regional Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730330168 PECOS PAC ID: 6800707225 Enrollment ID: O20090911000300 |
News Archive
In a new study researchers have found that Australia ranks near the top when it comes to alcohol abuse. The study was conducted by the National Drug and Alcohol Research Centre (NDARC) and it found that one in five Australians has a drinking problem and four in five go untreated for these problems. Professor Maree Teesson and her team analyzed data collected from almost 9,000 Australians aged 16 to 85 years for the National Survey of Mental Health and Wellbeing in 2007.
VNUS Medical Technologies, Inc. today announced that the U.S. Patent & Trademark Office has decided to allow a second continuation patent application related to the patents in the VNUS patent infringement lawsuit against suppliers of endovenous laser products. This comes on the heels of the Patent Office's decision last month to allow VNUS a separate patent application, also filed as a continuation of one of the patents in the lawsuit.
OncoSec Medical Inc., a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announces it has established the University of California San Francisco (UCSF) as the second enrolling site for its Phase II Merkel cell carcinoma clinical trial (OMS-I110).
RCSI University of Medicine and Health Sciences and LEO Pharma have partnered to better understand the role of a blood clotting protein in the spread of breast cancer.
Two new clinical reports shed light on why some people suffer from recurrent episodes of idiopathic anaphylaxis-a potentially life-threatening condition of unknown cause characterized by a drop in blood pressure, fainting episodes, difficulty in breathing, and wheezing.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward D Reese, MD 2360 Katy Ln, Poplar Bluff, MO 63901-2300 Ph: (573) 712-2546 | Dr Edward D Reese, MD 2360 Katy Ln, Poplar Bluff, MO 63901-2300 Ph: (573) 712-2546 |
News Archive
In a new study researchers have found that Australia ranks near the top when it comes to alcohol abuse. The study was conducted by the National Drug and Alcohol Research Centre (NDARC) and it found that one in five Australians has a drinking problem and four in five go untreated for these problems. Professor Maree Teesson and her team analyzed data collected from almost 9,000 Australians aged 16 to 85 years for the National Survey of Mental Health and Wellbeing in 2007.
VNUS Medical Technologies, Inc. today announced that the U.S. Patent & Trademark Office has decided to allow a second continuation patent application related to the patents in the VNUS patent infringement lawsuit against suppliers of endovenous laser products. This comes on the heels of the Patent Office's decision last month to allow VNUS a separate patent application, also filed as a continuation of one of the patents in the lawsuit.
OncoSec Medical Inc., a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announces it has established the University of California San Francisco (UCSF) as the second enrolling site for its Phase II Merkel cell carcinoma clinical trial (OMS-I110).
RCSI University of Medicine and Health Sciences and LEO Pharma have partnered to better understand the role of a blood clotting protein in the spread of breast cancer.
Two new clinical reports shed light on why some people suffer from recurrent episodes of idiopathic anaphylaxis-a potentially life-threatening condition of unknown cause characterized by a drop in blood pressure, fainting episodes, difficulty in breathing, and wheezing.
› Verified 6 days ago
Robert Francis Dorsey, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3098 Oak Grove Rd, Poplar Bluff, MO 63901 Phone: 573-776-2600 Fax: 573-776-2763 | |
Dr. Donna J Allmon, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 686 Lester St, Poplar Bluff, MO 63902 Phone: 573-686-2411 Fax: 573-686-8452 | |
Silvia Pagoada Vallecillo, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 Oak Grove Rd, Poplar Bluff, MO 63901 Phone: 573-776-2000 | |
Ibrahim Awawdeh, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2340 Katy Ln, Poplar Bluff, MO 63901 Phone: 573-290-3293 Fax: 669-280-5057 | |
Maxine A Theriot, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3098 Oak Grove Rd, Poplar Bluff, MO 63901 Phone: 573-686-8199 Fax: 573-686-8398 | |
Bennie N Till, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 686 Lester St, Poplar Bluff, MO 63901 Phone: 573-686-2411 Fax: 573-686-8452 |